Blogs

Immune Monitor - July 2023

By SITC Communications posted 07-27-2023 00:00

  

A Message from the President

It’s no secret that SITC is dedicated to supporting early career researchers and practitioners in the field of cancer immunotherapy! Both the Society and the Forward Fund are committed to expanding education and professional development opportunities for early career investigators and clinicians, with programming, funding, and award opportunities specifically designed to meet the needs of this unique group. We know that these key SITC members will become the next generation of leaders both for SITC, and the cancer immunotherapy field at large.
 
Many upcoming programs geared toward early career scientists and clinicians are about to launch, and I encourage you to learn more about them, and share them with early career folks who stand to benefit from these programs. To start, SITC recently opened registration for Cancer Immunotherapy Winter School (CIWS) taking place January 30–February 2, 2024 in Austin, TX, both in person and virtually. Over the same dates, SITC’s Clinical Immuno-Oncology Network (SCION) Workshop, an intimate immunotherapy clinical trial development program, will also take place with some CIWS programming included in the SCION Workshop. The SCION application period is now open through August 14, 2023. SITC is committed to financially assisting attendees of these programs with travel awards through its Forward Fund via a competitive review process.
 
Two additional programs will be opening soon. First, SITC’s Sparkathon 2024, a free and exclusive program that brings together early career investigators with established SITC leaders in cancer immunotherapy to foster leadership development, collaborations and scientific exchange will be held March 13–15, 2024. Second, SITC’s Spring Scientific, Metabolism at the Hub of Cancer Immunity, (travel awards will also be available!), will address the critical roles of immune, microbiome, and tumor metabolism in the treatment of cancer with immune-based strategies. The SITC Spring Scientific will be held March 10–12, 2024.
 
In addition to these education and award opportunities, SITC’s Fellowship programs continue to grow. SITC and the Forward Fund are excitedly looking forward to announcing the recipients of the 2023 SITC Fellowships in the next few months. This includes the prestigious Steven A. Rosenberg Scholars Award, which is rapidly becoming the most prestigious award for early career investigators in cancer immunotherapy. Also, SITC opened applications for the NCI Immunotherapy Fellowship on July 19. Stay tuned for further updates about these programs, and please remember to mark your calendar for the 2024 SITC Fellowship Program, which will open in early 2024.
 
For those who can’t wait until 2024 for programming, be sure to join us at the 38th Annual Meeting and Pre-Conference Programs in San Diego, CA, where SITC’s Early Career Scientist committee arranges a host of events. We will see many deserving early scientists receive their travel awards and fellowships during an award ceremony at the annual meeting. SITC takes great pride in watching the early career investigators grow with us as their careers progress.
 
Lastly, I’d like to mention SITC’s Immune Exclusion Virtual Summit, a wonderful educational opportunity for all taking place on September 18, 2023 from 12-5 p.m. EDT. Join us as we explore how the biology of immune exclusion manifests in different tumor types, discuss novel therapeutic opportunities, and review the novel tools available to study tumors with this distinct immunophenotype.
 
We are excited about building the future with you!


Sincerely,

Emens
Leisha A. Emens, MD, PhD
SITC President

 

The Latest at SITC

38TH ANNUAL MEETING & PRE-CONFERENCE PROGRAMS

Join us for SITC's 38th Annual Meeting & Pre-Conference Programs (SITC 2023), Nov. 1–5 in San Diego, CA. Renew your membership to attend at a discounted rate!
Submit abstracts containing new data for consideration as a Late-breaking Abstract (LBA) for oral and/or poster abstract presentation at SITC 2023. Late-breaking Abstract submissions are open through Sept. 6 at 5 p.m. PDT.

 

JOURNAL FOR IMMUNOTHERAPY OF CANCER (JITC) EDITOR-IN-CHIEF SEARCH

The Journal for ImmunoTherapy of Cancer (JITC) seeks applicants for its next Editor-in-Chief (EIC). Applicants should be an active scientist, academic, or clinician, well-known and well-regarded in their discipline, willing to serve a 5-year, renewable term with JITC beginning with onboarding in early 2024. Completed applications are due by 11:59 p.m. PT on Friday, Sept. 8, 2023.

SITC Immunotherapy Clinical Practice Guidelines (CPG)

SITC is pleased to offer free live and on-demand companion educational resources in support of the published Gynecologic and Gastrointestinal Clinical Practice Guidelines (CPG).

Register for Upcoming Companion Webinars

Practical Management Pearls for Immunotherapy for the Treatment of Gynecologic Cancer - SITC CPG Webinar Thursday, Sept. 7, 2023 | 12–1 p.m. CDT | Zoom Webinar

Case Studies in Immunotherapy for the Treatment of Gynecologic Cancer - SITC CPG Webinar Monday, Sept. 11, 2023 | 3–4 p.m. CDT | Zoom Webinar

SITC TARGETS FOR CANCER IO: A DEEP DIVE SERIES

This new series will include six live webinars addressing gene and cell therapy in immuno-oncology. Key leaders in the field who are experts in gene or cell therapy will provide an overview of the current state of the science and address questions about its future. As an added benefit, purchase three of the webinars and register for the remaining three at no additional cost.

SITC-NCI COMPUTATIONAL IMMUNO-ONCOLOGY 2023 WEBINAR SERIES

The Comp IO series consists of eight, hour-long free webinars featuring a moderator and faculty speaker leading instruction on a range of topics that cover a host of computational challenges of analyzing and integrating diverse assay data across the spectrum of immuno-oncology.

 

CANCER IMMUNOTHERAPY
WINTER SCHOOL
Save the Date!
Jan. 30–Feb. 2, 2024
Austin, TX or Virtual
Winter School participants gain a deep understanding of the core principles of tumor immunology and cancer immunotherapy, and developing areas in the field including biomarker technology, validation and clinical integration, clinical trial design, data analysis and considerations for combination therapies.
Travel award applications close Aug. 9.


ADVANCES IN CANCER IMMUNOTHERAPY

It's our 10th year of ACI programming! Join us for 15 topic-driven programs, completely free of charge for clinicians. Plus, these programs offer CME, CNE, CPE and MOC credit at no cost.
Upcoming program:

A Focus on Cellular Therapies & T Cell EngagersThursday, Aug. 17, 2023 | 12-4 p.m. EDT | Hybrid - virtual and Washington D.C.

Multidisciplinary Thoracic Cancers Symposium

The 2023 Multidisciplinary Thoracic Cancers Symposium  Collaboration and Precision in Thoracic Care: The Time is Now, will take place at the Sheraton New Orleans from November 30 through December 2, 2023. This a comprehensive meeting for radiation oncologists, medical oncologists, surgeons, physicists and practitioners specializing in thoracic cancers. This meeting is co-sponsored by: ASCO, ASTRO, SITC and STS. Registration and abstract submission are currently open and available.

Permalink